Associated Papers
Variable response of germline activating PDGFRB variants to receptor tyrosine kinase inhibitors: implications for treatment.
Cristea I et al.
European Journal of Human Genetics : Ejhg, 2025
Dermatomyofibromas harbor PDGFRB mutations - another tyrosine kinase-driven neoplasm.
Flucke U et al.
Virchows Archiv : an International Journal of Pathology, 2025
Temperature as a Key Modulator: Investigating Phosphorylation Patterns of p.Asn666 PDGFRB Variants and Their Role in Downstream Signaling.
Gladkauskas T et al.
Human Mutation, 2025
Corneal Vascularization Associated With a Novel PDGFRB Variant.
Gladkauskas T et al.
Investigative Ophthalmology & Visual Science, 2023
Clinical and molecular response to dasatinib in an adult patient with Penttinen syndrome.
Iznardo H et al.
American Journal of Medical Genetics. Part A, 2022
Temperature-dependent autoactivation associated with clinical variability of PDGFRB Asn666 substitutions.
Bredrup C et al.
Human Molecular Genetics, 2021
Clinical and molecular characteristics of Chinese non-small cell lung cancer patients with ERBB2 transmembrane domain mutations.
Fan Y et al.
Molecular Oncology, 2020
32478891 (PubMed )
Supplement: MOL2-14-1731-s002.xlsx › Sheet1
Select a paper to view details